ATE402933T1 - Neue sulfonamid-substituierte chroman-derivate verwendbar als beta 3 adrenorezeptor agonisten - Google Patents
Neue sulfonamid-substituierte chroman-derivate verwendbar als beta 3 adrenorezeptor agonistenInfo
- Publication number
- ATE402933T1 ATE402933T1 AT98958070T AT98958070T ATE402933T1 AT E402933 T1 ATE402933 T1 AT E402933T1 AT 98958070 T AT98958070 T AT 98958070T AT 98958070 T AT98958070 T AT 98958070T AT E402933 T1 ATE402933 T1 AT E402933T1
- Authority
- AT
- Austria
- Prior art keywords
- beta
- adrenoreceptor agonists
- chromene derivatives
- derivatives usable
- new sulfonamide
- Prior art date
Links
- 239000000556 agonist Substances 0.000 title 1
- 102000016959 beta-3 Adrenergic Receptors Human genes 0.000 title 1
- 108010014502 beta-3 Adrenergic Receptors Proteins 0.000 title 1
- 150000008371 chromenes Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99458597A | 1997-12-19 | 1997-12-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE402933T1 true ATE402933T1 (de) | 2008-08-15 |
Family
ID=25540825
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98958070T ATE402933T1 (de) | 1997-12-19 | 1998-11-17 | Neue sulfonamid-substituierte chroman-derivate verwendbar als beta 3 adrenorezeptor agonisten |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1054881B1 (de) |
| JP (1) | JP2001526281A (de) |
| AR (1) | AR016691A1 (de) |
| AT (1) | ATE402933T1 (de) |
| AU (1) | AU751015B2 (de) |
| CA (1) | CA2314925A1 (de) |
| CO (1) | CO4990952A1 (de) |
| DE (1) | DE69839821D1 (de) |
| IL (1) | IL136688A0 (de) |
| TW (1) | TW502032B (de) |
| WO (1) | WO1999032475A1 (de) |
| ZA (1) | ZA9810489B (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000256331A (ja) * | 1999-01-08 | 2000-09-19 | Nippon Bayer Agrochem Co Ltd | テトラゾリノン誘導体および除草剤としてのその用途 |
| ATE280167T1 (de) | 1999-07-23 | 2004-11-15 | Pfizer Prod Inc | Zwischenprodukte und ein verfahren zur herstellung von beta3-adrenergischer rezeptor- agoniste |
| EA200300145A1 (ru) * | 2000-07-13 | 2003-06-26 | Эли Лилли Энд Компани | АГОНИСТЫ β-АДРЕНЕРГИЧЕСКИХ РЕЦЕПТОРОВ |
| CZ20013076A3 (cs) | 2000-08-29 | 2002-04-17 | Kuraray Co., Ltd. | Způsob výroby chromankarboxylové kyseliny |
| EP1432696A1 (de) | 2001-10-04 | 2004-06-30 | Wyeth | Chromanderivate als 5-hydroxytryptamin-6-liganden |
| US7323462B2 (en) | 2002-12-10 | 2008-01-29 | Pfizer Inc. | Morpholine dopamine agonists |
| US7034051B2 (en) | 2003-08-28 | 2006-04-25 | Adolor Corporation | Fused bicyclic carboxamide derivatives and methods of their use |
| US20050222247A1 (en) * | 2003-12-13 | 2005-10-06 | Bayer Healthcare Ag | Chroman derivatives |
| CN102482228A (zh) | 2009-07-17 | 2012-05-30 | 盐野义制药株式会社 | 含有内酰胺或苯磺酰胺化合物的药物 |
| EP2536693A4 (de) | 2010-02-17 | 2014-08-06 | UNIVERSITé LAVAL | Substituierte 2-imidazolidone und analoga |
| CN108218845B (zh) * | 2016-12-21 | 2022-11-29 | 江苏柯菲平医药股份有限公司 | 一类色满-6-磺酰胺RORγ调节剂及其用途 |
| CN112107583A (zh) * | 2020-07-31 | 2020-12-22 | 东南大学 | 一种色满-6-磺酰胺RORγ调节剂的A晶型化合物的组合物及其制备方法和应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0091749A3 (de) * | 1982-04-08 | 1984-12-05 | Beecham Group Plc | Ethanolamin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen |
| US5451677A (en) * | 1993-02-09 | 1995-09-19 | Merck & Co., Inc. | Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity |
| IL113410A (en) * | 1994-04-26 | 1999-11-30 | Merck & Co Inc | Substituted sulfonamides having an asymmetric center and pharmaceutical compositions containing them |
| US5663194A (en) * | 1995-07-25 | 1997-09-02 | Mewshaw; Richard E. | Chroman-2-ylmethylamino derivatives |
| FR2746395B1 (fr) * | 1996-03-22 | 1998-04-17 | Adir | Nouveaux derives d'arylethanolamine et d'aryloxypropanolamine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| EP0801060A1 (de) * | 1996-04-09 | 1997-10-15 | Pfizer Inc. | Heterocyclische Beta-3 adrenergische Angonisten |
-
1998
- 1998-11-17 WO PCT/US1998/024627 patent/WO1999032475A1/en not_active Ceased
- 1998-11-17 ZA ZA9810489A patent/ZA9810489B/xx unknown
- 1998-11-17 AU AU14183/99A patent/AU751015B2/en not_active Ceased
- 1998-11-17 EP EP98958070A patent/EP1054881B1/de not_active Expired - Lifetime
- 1998-11-17 AT AT98958070T patent/ATE402933T1/de not_active IP Right Cessation
- 1998-11-17 IL IL13668898A patent/IL136688A0/xx unknown
- 1998-11-17 DE DE69839821T patent/DE69839821D1/de not_active Expired - Fee Related
- 1998-11-17 CA CA002314925A patent/CA2314925A1/en not_active Abandoned
- 1998-11-17 JP JP2000525412A patent/JP2001526281A/ja not_active Withdrawn
- 1998-11-17 TW TW087118968A patent/TW502032B/zh not_active IP Right Cessation
- 1998-11-18 AR ARP980105846A patent/AR016691A1/es not_active Application Discontinuation
- 1998-11-18 CO CO98067870A patent/CO4990952A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA9810489B (en) | 1999-05-20 |
| TW502032B (en) | 2002-09-11 |
| CO4990952A1 (es) | 2000-12-26 |
| AU1418399A (en) | 1999-07-12 |
| AR016691A1 (es) | 2001-07-25 |
| IL136688A0 (en) | 2001-06-14 |
| JP2001526281A (ja) | 2001-12-18 |
| EP1054881B1 (de) | 2008-07-30 |
| CA2314925A1 (en) | 1999-07-01 |
| EP1054881A1 (de) | 2000-11-29 |
| WO1999032475A1 (en) | 1999-07-01 |
| AU751015B2 (en) | 2002-08-08 |
| DE69839821D1 (de) | 2008-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID22891A (id) | Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan | |
| EE200000155A (et) | Taksoidide klassi kuuluvate derivaatide valmistamismeetod | |
| ID19802A (id) | Komposisi-komposisi berstruktur mikroskopik | |
| BR9711970A (pt) | Derivados 6,5-substitu¡do-heterobic¡clicos | |
| CY2010002I1 (el) | Στepεη φαρμακευτικη συνθεση πepιεχοντας παραγωγα βενζοφουρανιου | |
| BR9808777B1 (pt) | Composição dentifrícia dessensibilizadora de dois componentes. | |
| ATE226578T1 (de) | Benzofuranderivate als tachykininantagonisten | |
| EP0984779A4 (de) | Somatostatin agonisten | |
| PT1000048E (pt) | Derivados substituidos do 1,2,3,4-tetrahidronaftaleno | |
| DE69807760D1 (de) | Positiv-arbeitende Photoresistzusammensetzung | |
| ID25508A (id) | Komposisi dematologis | |
| DE69733395D1 (de) | Motorzusammensetzung | |
| ATE184015T1 (de) | Neue 19-nor-pregnen-derivate | |
| DE69812475T2 (de) | Photoresistzusammensetzung | |
| EP0758898A4 (de) | Activinantagonisten als verhütungsmittel | |
| DE69824822D1 (de) | Wässerige Antischaumzusammensetzungen | |
| NO20001483D0 (no) | Nye NPY-agonister | |
| DE69714265D1 (de) | Tetrahydrochinolinderivate als eaa antagonisten | |
| ATE402933T1 (de) | Neue sulfonamid-substituierte chroman-derivate verwendbar als beta 3 adrenorezeptor agonisten | |
| PT921125E (pt) | Derivados de 1,38-triaza-espiro 4,5 decan-4-ona | |
| DE69913697D1 (de) | Naphtho- und dihydrobenzothiophenderivate als cytotoxische antitumormittel | |
| ID17561A (id) | Komposisi untuk pemakaian luar | |
| DE69800779D1 (de) | Photopolymerisierbare Zusammensetzung | |
| MA26543A1 (fr) | Derives de pyrrolopyrrolone comme inhibiteurs d'elastase de neutrophiles. | |
| ID23250A (id) | Komposisi paroksetin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |